The white paper, Generative AI for Health in LMICs, examines how GenAI is being used in global health and what is needed to maximize its impact. Conducted by the Stanford Center for Digital Health in collaboration with the Alliance and with support from AHO, the research draws on expert insights from roundtables, interviews, surveys, and an analysis of 14 GenAI accelerator programs. On March 26, the Alliance hosted the virtual launch event of the white paper, exploring the top 5 key findings of the report.

Check out our 2024 AI and Global Health Discussion Series for more on AI and health, with thanks to Pfizer.

On January 15, the Bay Area Global Health Alliance hosted a panel discussion, Realizing Returns: Investment Opportunities in Emerging Markets, at the 2025 J.P. Morgan Healthcare Conference in San Francisco, followed by a reception to continue the conversation at Accenture San Francisco Innovation Hub. Together, these discussions explored investment opportunities in global health and partnerships using innovative financing models to drive both business and social returns in emerging markets.

Our 95+ member organizations are world-class academic institutions, innovative technology and private sector companies, start-ups, foundations, public sector institutions, and experienced nonprofits caring for the world’s most marginalized populations. With roots in the Bay Area, the Alliance has expanded to include organizations from across the United States and the world.

This year has been pivotal in strengthening the impact of the Bay Area Global Health Alliance as a trusted neutral convener, catalyst, and connector. We are proud to champion our members and help transform how diverse sectors collaborate to address the complex global health challenges of our time.